NCT05009771 Postoperative Pain Management of Caesarean Section
| NCT ID | NCT05009771 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mackay Memorial Hospital |
| Condition | Postoperative Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-02-23 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-02-23 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Caesarean section is one of the most frequent surgeries causing severe postoperative pain. Poor management of acute pain can contribute to postoperative complications, late recovery and the development of chronic pain. Moreover, it had been demonstrated that the intensity of postpartum pain is associated with depression. It is imperative to find out appropriate methods of postpartum pain alleviation. Currently, a lot of analgesic drugs and methods have been developed and used in clinical practice, such as patient-controlled analgesia, extended-release analgesics and multimodal analgesia. This prospective cohort study is aimed to investigate the outcome of each postoperative analgesic method used in caesarean section.
Eligibility Criteria
Inclusion Criteria: 1. Aged 20 to 40. 2. Planing to undergo caesarean section with spinal anesthesia. 3. Scheduled to undergo cesarean section between 37 and 40 weeks of gestation. 4. American Society of Anesthesiology Physical Class 1-2. 5. Planing to alleviate postoperative pain with intravenous patient-controlled analgesia or administration of NALDEBAIN. Exclusion Criteria: 1. Not willing to provide informed consent. 2. Unable to receive opioids or NSAIDs due to contraindication. 3. Long-term use of opioids or drug abuse. 4. Suffering from chronic pain disease. 5. Having medical history of mental illnesses. 6. Diagnosed with Pre-eclampsia or eclampsia. 7. Diagnosed with gestational diabetes. 8. Unsuitable for participation judged by investigator.
Contact & Investigator
Chi-Hsu Wang, M.D.
PRINCIPAL INVESTIGATOR
MacKay Memorial Hospital Tamsui Branch
Frequently Asked Questions
Who can join the NCT05009771 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 40 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05009771 currently recruiting?
Yes, NCT05009771 is actively recruiting participants. Contact the research team at s871017@gmail.com for enrollment information.
Where is the NCT05009771 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan, Taipei, Taiwan.
Who is sponsoring the NCT05009771 clinical trial?
NCT05009771 is sponsored by Mackay Memorial Hospital. The principal investigator is Chi-Hsu Wang, M.D. at MacKay Memorial Hospital Tamsui Branch. The trial plans to enroll 100 participants.